CEP290 p.Ile583Val
c.1747A>G · rs1459958084 · VCV991352
Computational evidence
| Protein change | ||
| AlphaMissense | 0.0661 | likely benign |
|---|---|---|
| REVEL | 0.171 | moderately benign-leaning |
| SaProt | LLR -6.67 | tolerated |
| ⇒ AlphaMissense, REVEL and SaProt all call this tolerated. | ||
| Splicing | ||
| SpliceAI | — | not assessed · no allele here is in the release |
| Constraint at this position | ||
| Conservation | phyloP 1.9 | GERP -4.3, phastCons 0.57 |
| Regional constraint | o/e 1.00 | unconstrained · MANE · 92 kb · p 0.89 · regional, not allelic |
| Overall | ||
| CADD | 0.706 | PHRED · no single calibrated threshold — expert panels disagree |
AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.
Population frequency
| Ancestry group | Frequency | 1 in |
|---|---|---|
| African / African-Americangrpmax | 0.00271% | 36,891 |
| European (non-Finnish) | 8.7e-05% | 1,149,556 |
Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.
Variant & gene context
- Gene
- CEP290
- Protein
- p.Ile583Val
- Coding
- c.1747A>G
- MANE Select
- NM_025114
- dbSNP
- rs1459958084
- Type
- single nucleotide variant
- Location
- chr12:88117110 (GRCh38)
- Gene constraint
- LOEUF 1.094 · pLI <0.01 · ClinGen HI gene assoc. with recessive phenotype (gnomAD)
- Structure
- AlphaFold pLDDT 60.90
- Residue 583
- the 'self-association (with itself or c-terminus)' region; a UniProt-annotated variant site (in lca10; also found in a patient with night blindness and hearing loss)
Disease context
Senior-Loken syndrome 6 — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatmentsAlso linked: Joubert syndrome 5Meckel syndrome, type 4Leber congenital amaurosis 10Bardet-Biedl syndrome 14Leber congenital amaurosis
For Senior-Loken syndrome (Orphanet):
- Inheritance
- Autosomal recessive
- Onset
- Adolescent, Adult, Childhood, Infancy
- Prevalence
- 1-9 / 1 000 000 (Worldwide)
Similar variants
- CEP290 c.1189+1G>A Pathogenic ★★★ same condition
- CEP290 c.1189+2T>C Pathogenic ★★★ same condition
- CEP290 c.297+1G>T Pathogenic ★★★ same condition
- CEP290 c.2991+1655A>G Pathogenic ★★★ same condition
- CEP290 c.6271-8T>G Pathogenic ★★★ same condition
- CEP290 p.Arg1272Ter Pathogenic ★★★ same condition
- CEP290 p.Arg1465Ter Pathogenic ★★★ same condition
- CEP290 p.Arg1752Trp Likely pathogenic ★★★ same condition
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/cep290-p-ile583val (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown